Metastatic Liposarcoma
7 clinical trials · Condition
◉ Watch Metastatic Liposarcoma
| Record | Firm | Date |
|---|---|---|
| Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery (NCT03074318) | Fred Hutchinson Cancer Center | 2017-09-28 |
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery (NCT03009201) | OHSU Knight Cancer Institute | 2017-03-10 |
| Sitravatinib in Advanced Liposarcoma and Other Soft Tissue Sarcomas (NCT02978859) | Columbia University | 2016-11-01 |
| Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery (NCT02500797) | National Cancer Institute (NCI) | 2015-08-13 |
| Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas (NCT02357810) | Northwestern University | 2015-03-21 |
| Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma (NCT01506596) | Vector Oncology | 2012-03-01 |
Track Metastatic Liposarcoma automatically
Every clearance here is in the API, with alerts when new ones post.